Given that these tumors were treated, the association observed between GSDMB/LC3B/Rab7 staining patterns and clinical behavior support the idea that GSDMB over-expression could promote protective autophagic response to therapy in HER2 positive cancer patients. This evidence concerns the gene ERBB2 and cancer.